Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-06-15
2010-06-29
Kwon, Brian-Yong S (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S330000, C546S177000
Reexamination Certificate
active
07745463
ABSTRACT:
This disclosure provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the disclosure is concerned with alkene piperidine derivatives that possess unique antiviral activity. More particularly, the present disclosure relates to compounds useful for the treatment of HIV and AIDS.
REFERENCES:
patent: 7348337 (2005-03-01), Wang at al.
patent: 2004/0063744 (2004-04-01), Wang et al.
patent: 2005/0209246 (2005-09-01), Ueda et al.
patent: 2005/0215543 (2005-09-01), Lin et al.
patent: 2005/0215544 (2005-09-01), Lin et al.
patent: 2005/0215545 (2005-09-01), Lin et al.
patent: WO 03/103607 (2003-12-01), None
patent: WO2005/016344 (2005-02-01), None
patent: WO2005/121094 (2005-12-01), None
Blair, et al., “HIV-1 entry—an expanding portal for drug discovery,” Drug Discovery Today, vol. 5, Nov. 5, May 2000, pp. 183-194.
Hotoda, “Small-molecule inhibitors of HIV-1 entry via chemokine receptors,” Drugs of the Future, 1999, 24(12), pp. 1355-1362.
Meanwell, “Inhibitors of the entry of HIV into host cells,” Current Opinion in Drug Discovery and Development, 2003, 6(4), pp. 451-461.
Sodroski, “HIV-1 Entry Inhibitors in the Side Pocket,” Cell, vol. 99, Oct. 29, 1999, pp. 243-246.
Wang, et al., “Modification and structure-activity relationship of a small molecule HIV-1 inhibitor targeting the viral envelope glycoprotein gp120,” Org. Bio. Chem., 2005, 3, pp. 1781-1786.
Han Ying
Kadow John F.
Meanwell Nicholas A.
Wang Tao
Zhang Zhongxing
Baek Bong-Sook
Bristol--Myers Squibb Company
Kwon Brian-Yong S
Levis John F.
LandOfFree
Alkene piperidine derivatives as antiviral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkene piperidine derivatives as antiviral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkene piperidine derivatives as antiviral agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4172210